ArticleCancer cell international2023

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.

Seol Hwa Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.